首页> 美国卫生研究院文献>Bioinformatics >WaveCNV: allele-specific copy number alterations in primary tumors and xenograft models from next-generation sequencing
【2h】

WaveCNV: allele-specific copy number alterations in primary tumors and xenograft models from next-generation sequencing

机译:WaveCNV:来自下一代测序的原发肿瘤和异种移植模型中的等位基因特异性拷贝数改变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Motivation: Copy number variations (CNVs) are a major source of genomic variability and are especially significant in cancer. Until recently microarray technologies have been used to characterize CNVs in genomes. However, advances in next-generation sequencing technology offer significant opportunities to deduce copy number directly from genome sequencing data. Unfortunately cancer genomes differ from normal genomes in several aspects that make them far less amenable to copy number detection. For example, cancer genomes are often aneuploid and an admixture of diploidon-tumor cell fractions. Also patient-derived xenograft models can be laden with mouse contamination that strongly affects accurate assignment of copy number. Hence, there is a need to develop analytical tools that can take into account cancer-specific parameters for detecting CNVs directly from genome sequencing data.>Results: We have developed WaveCNV, a software package to identify copy number alterations by detecting breakpoints of CNVs using translation-invariant discrete wavelet transforms and assign digitized copy numbers to each event using next-generation sequencing data. We also assign alleles specifying the chromosomal ratio following duplication/loss. We verified copy number calls using both microarray (correlation coefficient 0.97) and quantitative polymerase chain reaction (correlation coefficient 0.94) and found them to be highly concordant. We demonstrate its utility in pancreatic primary and xenograft sequencing data.>Availability and implementation: Source code and executables are available at . The segmentation algorithm is implemented in MATLAB, and copy number assignment is implemented Perl.>Contact: >Supplementary information: are available at Bioinformatics online.
机译:>动机:拷贝数变异(CNV)是基因组变异的主要来源,在癌症中尤为重要。直到最近,微阵列技术已被用于表征基因组中的CNV。但是,下一代测序技术的进步为直接从基因组测序数据推论出拷贝数提供了巨大的机会。不幸的是,癌症基因组在几个方面与正常基因组有所不同,这使得它们很难被拷贝数检测。例如,癌症基因组通常是非整倍体和二倍体/非肿瘤细胞级分的混合物。同样,源自患者的异种移植模型可能会充满小鼠污染,从而严重影响拷贝数的准确分配。因此,需要开发一种分析工具,该工具可以考虑到癌症特有的参数以直接从基因组测序数据中直接检测CNV。>结果:我们已经开发了WaveCNV,这是一种用于识别拷贝数变化的软件包通过使用平移不变的离散小波变换检测CNV的断点,并使用下一代测序数据为每个事件分配数字化的拷贝数。我们还分配了等位基因,指定了重复/缺失后的染色体比率。我们使用微阵列(相关系数0.97)和定量聚合酶链反应(相关系数0.94)验证了拷贝数调用,发现它们高度一致。我们在胰腺主要和异种移植测序数据中展示了其实用性。>可用性和实现:源代码和可执行文件位于。分割算法是在MATLAB中实现的,副本号分配是在Perl中实现的。>联系方式: >补充信息:可从Bioinformatics在线获得。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号